Javascript must be enabled to continue!
Variable Expression of Fetal Hemoglobin In Sickle Cell Disease Patients From Oman
View through CrossRef
Abstract
Abstract 4808
Although sickle cell disease (SCD) is a recessively inherited monogenic disorder, its clinical expression is variable from patient to patient, even within the same family; and, both heritable and environmental factors significantly contribute to this inter-patient difference in disease severity. The most prominent genetic modifiers include co-inherited alpha thalassaemia, over expression of fetal hemoglobin (HbF) in adulthood, and the excessive production of insoluble bilirubin. The purpose of this study was to ascertain the emerging role of HbF by studying several known SNP's in Chromosome 2, 6 and 11 that are involved in modulating the fetal hemoglobin levels in patients from Oman. This case-control study was conducted at Sultan Qaboos University Hospital from February to May 2010. Eighty eight SCD patients were consecutively studied along with forty four Omani blood donors who were selected randomly to complete a 2:1 case-control enrollment after an informed consent. Whole blood samples were collected in EDTA tubes from SCD patients and donors. DNA was extracted from the whole blood after Complete Blood Count and High Performance Liquid Chromatography were performed on the patient and donor samples. The molecular analysis included genotyping of BCL11A, HBSIL-MYB, HBG2 SNP's by direct DNA sequencing with 3100 genetic analyzer (ABI systems, Illinois, USA) using Tag SNP's in each category namely rs11886868, rs4671393 (BCL11A-Ch.2), rs7776054, rs9399137, rs4895441 (HBSIL-MYB-Ch.6), & rs7482144 (HBG2-Ch.11) to correlate these SNP's with the HbF expression in the SCD patients.
A stepwise regression analysis result of the 6 SNP's genotyped at the BCL11A, HBSIL-MYB, and HBG2 gene locus were correlated to the HbF levels in our SCD study cohort and is shown below. At each step, the least significant SNP was removed, until all SNP's left in the multivariate model were significant. The model at step 4 has the best goodness of fit value, as assessed by the likelihood ratio test, than models 1, 2 & 3. [Table]
Step 1: HbF levels~rs7482144 + rs7776054 + rs9399137 + rs4895441 + rs11886868 + rs4671393
Step 2: HbF levels~rs7482144 + rs7776054 + rs9399137 + rs11886868 + rs4671393
Step 3: HbF levels~rs7482144 + rs9399137 + rs11886868+ rs4671393
Step 4: HbF levels~rs7482144 + rs9399137 + rs4671393Table:Fetal hemoglobin association results for SNPs at the BCL11A, HBS1L-MYB, and HBG2 gene loci in the sickle cell cohort from Oman.SNP'sChromosomeMAF# (allele)Effect sizeStandard Errorp-valuers7482144110.262 (A)4.1610.6890.000*rs939913760.0875 (C)5.5631.2660.000*rs467139320.59 (A)-1.6610.8360.05*#MAF, minor allele frequency. Minor alleles (positive strand) are given in parenthesis.*A p value of <0.05 was considered as highly significant.
Our study has demonstrated a significant association between the BCL11A, HBSIL-MYB, HBG2 SNP's and HbF levels. Together these 6 SNP's accounted for ~46% variation in the HbF levels in our SCD study subjects and in part explains the clinical heterogeneity seen in these patients. Three SNP's one each in Chromosome 2, 6 and 11 namely rs4671393, rs9399137 and rs7482144 respectively demonstrated the strongest effect on HbF levels.
Disclosures:
Alkindi: Sultan Qaboos University: Employment, Research Funding. Krishnamoorthy: INSERM U763: Employment, Research Funding. Pathare: Sultan Qaboos University: Employment, Research Funding.
American Society of Hematology
Title: Variable Expression of Fetal Hemoglobin In Sickle Cell Disease Patients From Oman
Description:
Abstract
Abstract 4808
Although sickle cell disease (SCD) is a recessively inherited monogenic disorder, its clinical expression is variable from patient to patient, even within the same family; and, both heritable and environmental factors significantly contribute to this inter-patient difference in disease severity.
The most prominent genetic modifiers include co-inherited alpha thalassaemia, over expression of fetal hemoglobin (HbF) in adulthood, and the excessive production of insoluble bilirubin.
The purpose of this study was to ascertain the emerging role of HbF by studying several known SNP's in Chromosome 2, 6 and 11 that are involved in modulating the fetal hemoglobin levels in patients from Oman.
This case-control study was conducted at Sultan Qaboos University Hospital from February to May 2010.
Eighty eight SCD patients were consecutively studied along with forty four Omani blood donors who were selected randomly to complete a 2:1 case-control enrollment after an informed consent.
Whole blood samples were collected in EDTA tubes from SCD patients and donors.
DNA was extracted from the whole blood after Complete Blood Count and High Performance Liquid Chromatography were performed on the patient and donor samples.
The molecular analysis included genotyping of BCL11A, HBSIL-MYB, HBG2 SNP's by direct DNA sequencing with 3100 genetic analyzer (ABI systems, Illinois, USA) using Tag SNP's in each category namely rs11886868, rs4671393 (BCL11A-Ch.
2), rs7776054, rs9399137, rs4895441 (HBSIL-MYB-Ch.
6), & rs7482144 (HBG2-Ch.
11) to correlate these SNP's with the HbF expression in the SCD patients.
A stepwise regression analysis result of the 6 SNP's genotyped at the BCL11A, HBSIL-MYB, and HBG2 gene locus were correlated to the HbF levels in our SCD study cohort and is shown below.
At each step, the least significant SNP was removed, until all SNP's left in the multivariate model were significant.
The model at step 4 has the best goodness of fit value, as assessed by the likelihood ratio test, than models 1, 2 & 3.
[Table]
Step 1: HbF levels~rs7482144 + rs7776054 + rs9399137 + rs4895441 + rs11886868 + rs4671393
Step 2: HbF levels~rs7482144 + rs7776054 + rs9399137 + rs11886868 + rs4671393
Step 3: HbF levels~rs7482144 + rs9399137 + rs11886868+ rs4671393
Step 4: HbF levels~rs7482144 + rs9399137 + rs4671393Table:Fetal hemoglobin association results for SNPs at the BCL11A, HBS1L-MYB, and HBG2 gene loci in the sickle cell cohort from Oman.
SNP'sChromosomeMAF# (allele)Effect sizeStandard Errorp-valuers7482144110.
262 (A)4.
1610.
6890.
000*rs939913760.
0875 (C)5.
5631.
2660.
000*rs467139320.
59 (A)-1.
6610.
8360.
05*#MAF, minor allele frequency.
Minor alleles (positive strand) are given in parenthesis.
*A p value of <0.
05 was considered as highly significant.
Our study has demonstrated a significant association between the BCL11A, HBSIL-MYB, HBG2 SNP's and HbF levels.
Together these 6 SNP's accounted for ~46% variation in the HbF levels in our SCD study subjects and in part explains the clinical heterogeneity seen in these patients.
Three SNP's one each in Chromosome 2, 6 and 11 namely rs4671393, rs9399137 and rs7482144 respectively demonstrated the strongest effect on HbF levels.
Disclosures:
Alkindi: Sultan Qaboos University: Employment, Research Funding.
Krishnamoorthy: INSERM U763: Employment, Research Funding.
Pathare: Sultan Qaboos University: Employment, Research Funding.
Related Results
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country
Background: Sickle cell disease in pregnancy is associated with high maternal and fetal mortality. However, studies reporting pregnancy, fetal, and neonatal outcomes in women with ...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Retrospective Analysis of Transfusions on Sickle Cell–Related Morbidity in Pregnancy
Retrospective Analysis of Transfusions on Sickle Cell–Related Morbidity in Pregnancy
Abstract
Presentation Date: 6/8/2024
Presentation Start Time: 6:00 PM
...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Sickle cell trait, knowledge, attitudes, practices and perceptions regarding sickle cell disease among people living in Yaoundé, Cameroon
Sickle cell trait, knowledge, attitudes, practices and perceptions regarding sickle cell disease among people living in Yaoundé, Cameroon
Sickle cell disease is the most common autosomal recessive disease in sub-Saharan Africa. Our study aimed to determine the sickle cell trait, to assess knowledge, attitudes, practi...
High acceptability of newborn screening for sickle cell disease among post-natal mothers in Western Kenya
High acceptability of newborn screening for sickle cell disease among post-natal mothers in Western Kenya
Sickle cell disease is a genetically inherited blood disorder that manifests early in life with resultant significant health complications. Globally, nearly three quarters of all a...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Selected Testing of Newborns for Sickle Cell Disease
Selected Testing of Newborns for Sickle Cell Disease
There are two main reasons for sickle cell testing: the early detection of those with sickle cell disease and the detection of the carrier state, sickle cell trait. The mortality o...

